Login / Signup

Motor neuron disease in three asymptomatic pVal50Met <i>TTR</i> gene carriers.

Cláudia Santos SilvaMiguel Oliveira SantosMarta GromichoAna Pronto-LaborinhoIsabel ConceiçãoMamede de Carvalho
Published in: Amyotrophic lateral sclerosis & frontotemporal degeneration (2022)
We describe three unrelated patients with sporadic motor neuron disease (MND) and hereditary amyloid transthyretin (ATTRv) amyloidosis family history, who were asymptomatic carriers of the pVal50Met mutation of transthyretin (TTR) gene. Patients 1 and 2 were a 43-year-old man with a spinal-onset of ALS and a 37-year-old woman with a bulbar-onset of ALS, who died due to respiratory complications five and two years after disease onset, respectively. Patient 3 is a 52-year-old woman, with a two-year history of a probable primary lateral sclerosis, and a frontotemporal dysfunction. Imaging, cerebrospinal fluid (CSF) and nerve conduction and small fiber tests were normal in all. Genetic testing for ALS was negative in the two patients tested. Previous studies in MND patients have identified reduced TTR levels in CSF and neuronal gene overexpression, suggesting a neuroprotective role of TTR. The association of MND in patients with <i>TTR</i> gene mutations has not yet been described.
Keyphrases
  • ejection fraction
  • newly diagnosed
  • cerebrospinal fluid
  • spinal cord
  • mass spectrometry
  • late onset
  • cell proliferation
  • genome wide
  • dna methylation
  • tyrosine kinase
  • risk factors
  • cerebral ischemia
  • case control